We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Pilot Evaluation of a New Galyfilcon A Contact Lens Compared to a Marketed Galyfilcon A Contact Lens
Updated: 12/31/1969
A Multi-site Dispensing Evaluation Comparing a New Galyfilcon A Prototype Lens With a Marketed Galyfilcon A Contact Lens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
Updated: 12/31/1969
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Updated: 12/31/1969
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects With Active Thyroid Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Updated: 12/31/1969
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials